Literature DB >> 25959030

Delineating the spectrum of impairments, disabilities, and rehabilitation needs in methylmalonic acidemia (MMA).

Yiouli P Ktena1, Scott M Paul2, Natalie S Hauser1, Jennifer L Sloan1, Andrea Gropman3, Irini Manoli1, Charles P Venditti1.   

Abstract

Methylmalonic acidemia patients have complex rehabilitation needs that can be targeted to optimize societal independence and quality of life. Thirty-seven individuals with isolated MMA (28 mut, 5 cblA, 4 cblB), aged 2-33 years, were enrolled in a natural history study, and underwent age-appropriate clinical assessments to characterize impairments and disabilities. Neurological examination and brain imaging studies were used to document movement disorders and the presence of basal ganglia injury. A range of impairments and disabilities were identified by a team of physical medicine experts. Movement disorders, such as chorea and tremor, were common (n = 31, 83%), even among patients without evidence of basal ganglia injury. Joint hypermobility (n = 24, 69%) and pes planus (n = 22, 60%) were frequent and, in many cases, under-recognized. 23 (62%) patients required gastrostomy feedings. 18/31 patients >4 years old (58%) had difficulties with bathing and dressing. 16 of 23 school-aged patients received various forms of educational support. Five of the 10 adult patients were employed or in college; three lived independently. Unmet needs were identified in access to rehabilitation services, such as physical therapy (unavailable to 14/31), and orthotics (unavailable to 15/22). We conclude that patients with MMA are challenged by a number of functional limitations in essential activities of mobility, self-care, and learning, in great part caused by movement disorders and ligamentous laxity. Early assessment, referral, and implementation of age-appropriate rehabilitation services should significantly improve independence and quality of life.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  basal ganglia; disabilities; methylmalonic acidemia; outcome; rehabilitation

Mesh:

Year:  2015        PMID: 25959030      PMCID: PMC9017244          DOI: 10.1002/ajmg.a.37127

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  29 in total

Review 1.  Exercise in neuromuscular diseases.

Authors:  R Ted Abresch; Gregory T Carter; Jay J Han; Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

2.  Dynamic balance during gait in children and adults with Generalized Joint Hypermobility.

Authors:  S Falkerslev; C Baagø; T Alkjær; L Remvig; J Halkjær-Kristensen; P K Larsen; B Juul-Kristensen; E B Simonsen
Journal:  Clin Biomech (Bristol, Avon)       Date:  2013-02-01       Impact factor: 2.063

3.  Joint hypermobility syndrome in childhood. A not so benign multisystem disorder?

Authors:  N Adib; K Davies; R Grahame; P Woo; K J Murray
Journal:  Rheumatology (Oxford)       Date:  2005-02-22       Impact factor: 7.580

Review 4.  The management and outcome of propionic and methylmalonic acidaemia.

Authors:  J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Long-term follow-up of 77 patients with isolated methylmalonic acidaemia.

Authors:  E R Baumgarter; C Viardot
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Long term outcome of organic acidurias: survey of 105 French cases (1967-1983).

Authors:  R Rousson; P Guibaud
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients.

Authors:  Cyril Gitiaux; Emmanuel Roze; Kiyoka Kinugawa; Constance Flamand-Rouvière; Nathalie Boddaert; Emmanuelle Apartis; Vassili Valayannopoulos; Guy Touati; Jacques Motte; David Devos; Karine Mention; Dries Dobbelaere; Diana Rodriguez; Agathe Roubertie; Brigitte Chabrol; François Feillet; Marie Vidailhet; Nadia Bahi-Buisson
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

8.  Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia.

Authors:  S B van der Meer; F Poggi; M Spada; J P Bonnefont; H Ogier; P Hubert; E Depondt; D Rapoport; D Rabier; C Charpentier
Journal:  J Pediatr       Date:  1994-12       Impact factor: 4.406

9.  Long-term outcome in methylmalonic aciduria: a series of 30 French patients.

Authors:  M A Cosson; J F Benoist; G Touati; M Déchaux; N Royer; L Grandin; J P Jais; N Boddaert; V Barbier; I Desguerre; P M Campeau; D Rabier; V Valayannopoulos; P Niaudet; P de Lonlay
Journal:  Mol Genet Metab       Date:  2009-03-24       Impact factor: 4.797

Review 10.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.

Authors:  Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

View more
  8 in total

Review 1.  Review of neuropsychological outcomes in isolated methylmalonic acidemia: recommendations for assessing impact of treatments.

Authors:  Susan E Waisbren
Journal:  Metab Brain Dis       Date:  2022-03-29       Impact factor: 3.655

Review 2.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

3.  Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report.

Authors:  Qiuxia Chen; Huaying Bao; Hongmei Wu; Sanlong Zhao; Songming Huang; Fei Zhao
Journal:  Exp Ther Med       Date:  2017-08-18       Impact factor: 2.447

4.  Newborn Screening for Methylmalonic Acidemia in a Chinese Population: Molecular Genetic Confirmation and Genotype Phenotype Correlations.

Authors:  Wei Zhou; Huizhong Li; Chuanxia Wang; Xiuli Wang; Maosheng Gu
Journal:  Front Genet       Date:  2019-01-23       Impact factor: 4.599

5.  Clinical picture and treatment effects in 5 patients with Methylmalonic aciduria related to MMAA mutations.

Authors:  Dorota Wesół-Kucharska; Magdalena Kaczor; Magdalena Pajdowska; Ewa Ehmke Vel Emczyńska-Seliga; Anna Bogdańska; Dariusz Kozłowski; Dorota Piekutowska-Abramczuk; Elżbieta Ciara; Dariusz Rokicki
Journal:  Mol Genet Metab Rep       Date:  2020-01-08

6.  Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis.

Authors:  Arnaud Wiedemann; Abderrahim Oussalah; Nathalie Lamireau; Maurane Théron; Melissa Julien; Jean-Philippe Mergnac; Baptiste Augay; Pauline Deniaud; Tom Alix; Marine Frayssinoux; François Feillet; Jean-Louis Guéant
Journal:  Cell Rep Med       Date:  2022-06-27

7.  Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?

Authors:  Hanneke A Haijes; Femke Molema; Mirjam Langeveld; Mirian C Janssen; Annet M Bosch; Francjan van Spronsen; Margot F Mulder; Nanda M Verhoeven-Duif; Judith J M Jans; Ans T van der Ploeg; Margreet A Wagenmakers; M Estela Rubio-Gozalbo; Martijn C G J Brouwers; Maaike C de Vries; Janneke G Langendonk; Monique Williams; Peter M van Hasselt
Journal:  J Inherit Metab Dis       Date:  2019-12-22       Impact factor: 4.982

Review 8.  Mitochondrial disease, mitophagy, and cellular distress in methylmalonic acidemia.

Authors:  Alessandro Luciani; D Sean Froese; Matthew C S Denley; Larissa P Govers; Vincenzo Sorrentino
Journal:  Cell Mol Life Sci       Date:  2021-09-15       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.